Browsing by Author "Granell, Miquel"

Sort by: Order: Results:

  • Barata, Anna; Rodrigo Martino, Rodrigo; Gich, Ignasi; García-Cadenas, Irene; Abella Monreal, Eugenia; Barba, Pere; Briones, Javier; Brunet, Salut; Esquirol, Albert; García-Pallarols, Francesc; Garrido, Ana; Granell, Miquel; Martinez , Jaume; Mensa , Irene; Novelli, Silvana; Sanchez Gonzalez, Blanca; Valcárcel, David; Sierra, Jordi (Elsevier, 2017)
    Patient and physician agreement on the most significant symptoms is associated with treatment outcomes and satisfaction with care. Thus, we sought to assess patient and physician agreement on patient-reported quality of ...
  • Granell, Miquel; Calvo Gonzalo, Xavier; Garcia-Guiñón, Antoni; Escoda, Lourdes; Abella Monreal, Eugenia; Martínez, Clara M.; Teixidó, Montserrat; Gimenez, Mª Teresa; Senín Magan, Maria Alicia; Sanz, Patricia; Campoy, Desirée; Vicent, Ana; Arenillas Rocha, Leonor; Rosiñol, Laura; Sierra, Jorge; Blade, Joan; Fernández de Larrea, Carlos; GEMMAC (Grup per l’estudi del mieloma i l’amiloïdosi de Catalunya) (Ferrata Storti Foundation, 2017)
    The presence of circulating plasma cells in patients with multiple myeloma is considered a marker for highly proliferative disease. In the study herein, the impact of circulating plasma cells assessed by cytology on survival ...
  • García-Sanz, Ramón; Albert, Oriol; Moreno, María J.; Rubia, Javier de la; Payer, Angel R.; Hernández, Miguel T.; Palomera, Luis; Teruel, Ana I.; Blanchard, María J.; Gironella, Mercedes; Ribas, Paz; Bargay, Joan; Abella Monreal, Eugenia; Granell, Miquel; Ocio, Enrique M.; Ribera, Josep M.; San Miguel, Jesús F.; Mateos, María V.; Spanish Myeloma Group (GEM/PETHEMA). (Ferrata Storti Foundation, 2015)
    This study analyzed the anti-myeloma effect of zoledronic acid monotherapy by investigating patients at the time of asymptomatic biochemical relapse. One hundred patients were randomized to receive either zoledronic acid ...